ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print October 24, 2007, 10.1183/09031936.00036707
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Renda, T.
Right arrow Articles by Saetta, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Renda, T.
Right arrow Articles by Saetta, M.
Eur Respir J 2008; 31:62-69
Copyright ©ERS Journals Ltd 2008

Increased activation of p38 MAPK in COPD

T. Renda1,2, S. Baraldo3, G. Pelaia1, E. Bazzan3, G. Turato3, A. Papi4, P. Maestrelli5, R. Maselli1, A. Vatrella2, L. M. Fabbri6, R. Zuin, S. A. Marsico2 and M. Saetta3

1 Dept of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Catanzaro, 2 Dept of Cardiothoracic and Respiratory Sciences, Second University of Naples, Naples, Depts of 3 Cardiac, Thoracic and Vascular Sciences, and 5 Environmental Medicine and Public Health, University of Padova, Padova, 4 Dept of Clinical and Experimental Medicine, University of Ferrara, Ferrara, and 6 Dept of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, Italy.

CORRESPONDENCE: M. Saetta, Dept of Cardiac, Thoracic and Vascular Sciences, Section of Respiratory Diseases, University of Padova, via Giustiniani 3, Padova, Italy. Fax: 39 0498213110. E-mail: marina.saetta{at}unipd.it

Keywords: Airflow limitation, chronic obstructive pulmonary disease, cigarette smoking, phospho-p38 mitogen-activated protein kinases

Received: March 27, 2007
Accepted October 16, 2007

Inflammation, oxidative stress and apoptosis, which are involved in chronic obstructive pulmonary disease (COPD) pathogenesis, may activate the p38 subgroup of mitogen-activated protein kinases (MAPKs). Therefore, the aim of the present study was to evaluate the expression of the phosphorylated, active form of p38 MAPK (phospho-p38) in the lungs of COPD patients.

Surgical specimens were obtained from 18 smokers with COPD at different stages of disease severity, plus nine smoking and eight nonsmoking subjects with normal lung function. Phospho-p38+ cells were quantified by immunohistochemistry in both alveolar spaces and alveolar walls. Moreover, a Western blot analysis of phospho-p38 and total p38{alpha} isoform expressed by alveolar macrophages was performed.

Phospho-p38+ alveolar macrophages and phospho-p38+ cells in alveolar walls were increased in patients with severe and mild/moderate COPD, compared with smoking and nonsmoking controls. Moreover, they were inversely correlated to values of forced expiratory volume in one second (FEV1) and FEV1/forced vital capacity. Western blot analysis showed that phosphorylated p38, but not the total p38{alpha} isoform, was specifically increased in alveolar macrophages from COPD patients.

Activation of the p38 mitogen-activated protein kinase pathway appears to be involved in the pathogenesis of chronic obstructive pulmonary disease. The present findings suggest that this protein may be a suitable pharmacological target for therapeutic intervention.




This article has been cited by other articles:


Home page
Eur Respir JHome page
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Respiratory DiseaseHome page
A. Zanini, A. Chetta, and D. Olivieri
Review: Therapeutic perspectives in bronchial vascular remodeling in COPD
Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 179 - 187.
[Abstract] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Yao, I. Edirisinghe, S. Rajendrasozhan, S.-R. Yang, S. Caito, D. Adenuga, and I. Rahman
Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice
Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1174 - L1186.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Respiratory DiseaseHome page
G. Braganza, R. Chaudhuri, and N. C. Thomson
Review: Treating patients with respiratory disease who smoke
Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 95 - 107.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the European Respiratory Society.